IRADIMED CORPORATION (IRMD) Dividend Safety
- Dividend payout ratio · 12 months: Value 68.66%; Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | 68.66% | Cash dividends paid / net income. Period ending 2026-06-30. $15.83M ÷ $23.06M × 100 ≈ 68.66% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | 15.83M USD | Payments of Dividends |
| Net income · 12 months | 23.06M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | $15.83M | $23.06M | 68.66% |
| 2026-03-31 | $15.43M | $23.61M | 65.37% |
| 2025-12-31 | $15.04M | $22.48M | 66.90% |
| 2025-09-30 | $8.39M | $21.18M | 39.59% |
| 2025-06-30 | $8.12M | $20.66M | 39.33% |
| 2025-03-31 | $7.86M | $19.78M | 39.74% |
| 2024-12-31 | $13.68M | $19.23M | 71.11% |
| 2024-09-30 | $11.78M | $18.63M | 63.22% |
| 2024-06-30 | $9.88M | $18.64M | 52.97% |
| 2024-03-31 | $7.98M | $17.92M | 44.50% |
| 2023-12-31 | $13.22M | $17.19M | 76.91% |
| 2023-09-30 | $13.22M | $16.33M | 80.99% |
| 2023-06-30 | $13.22M | $14.69M | 90.03% |
| 2023-03-31 | $13.22M | $13.75M | 96.18% |
| 2022-12-31 | $12.56M | $12.83M | 97.90% |
| 2022-09-30 | (m) | $13.05M | (m) |
| 2022-06-30 | (m) | $12.20M | (m) |
| 2022-03-31 | (m) | $10.43M | (m) |
| 2021-12-31 | (m) | $9.33M | (m) |
| 2021-09-30 | (m) | $6.07M | (m) |
| 2021-06-30 | (m) | $4.57M | (m) |
| 2021-03-31 | (m) | $986.64K | (m) |
| 2020-12-31 | (m) | $1.37M | (m) |
| 2020-09-30 | (m) | $3.97M | (m) |
| 2020-06-30 | (m) | $5.35M | (m) |
| 2020-03-31 | (m) | $9.55M | (m) |
| 2019-12-31 | (m) | $9.63M | (m) |
| 2019-09-30 | (m) | $8.10M | (m) |
| 2019-06-30 | (m) | $8.04M | (m) |
| 2019-03-31 | (m) | $7.31M | (m) |
| 2018-12-31 | (m) | $6.30M | (m) |
| 2018-09-30 | (m) | $4.78M | (m) |
| 2018-06-30 | (m) | $2.57M | (m) |
| 2018-03-31 | (m) | $1.57M | (m) |
| 2017-12-31 | (m) | $499.76K | (m) |
| 2017-09-30 | (m) | $1.46M | (m) |
| 2017-06-30 | (m) | $2.83M | (m) |
| 2017-03-31 | (m) | $4.70M | (m) |
| 2016-12-31 | (m) | $7.21M | (m) |
| 2016-09-30 | (m) | $8.48M | (m) |
| 2016-06-30 | (m) | $8.79M | (m) |
| 2016-03-31 | (m) | $8.32M | (m) |
| 2015-12-31 | (m) | $7.53M | (m) |
| 2015-09-30 | (m) | $5.40M | (m) |
| 2015-06-30 | (m) | $3.77M | (m) |
| 2015-03-31 | (m) | $3.01M | (m) |
| 2014-12-31 | (m) | $2.05M | (m) |
| 2014-09-30 | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) |
| 2013-12-31 | (m) | $1.94M | (m) |
| 2013-09-30 | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |